Robert Califf, MD, MACC
Head of Strategy and Policy
Verily Life Sciences and Google Health
Advances at the Intersection of Digital Health, Electronic Health Records, and Pragmatic Clinical Trials: Keynote-Can the COVID-19 Crisis Lead to Reformation of the Evidence Generation Ecosystem?
Electronic health records; Digital health; Mobile health; Coronavirus; COVID-19; Ecosystem; Clinical trials; Evidence generation
- The HERO Registry and RECOVERY Trial are good examples of a rapid clinical research response to the urgent COVID-19 health crisis.
- Among the essential steps to move the evidence generation system in the right direction:
- Evaluate what has and has not worked in the changes made in response to the crisis
- Allocate a significant part of recovery funding to transition issues in evidence generation, especially at the interface of medicine and public health
- Increase purposefulness by creating methods for deciding the most important questions and rewarding behavior that gets those questions answered quickly
The COVID-19 pandemic has shone a spotlight on disparities in our current healthcare delivery system. How can we avoid leaving the most vulnerable of society behind?
Telemedicine can be a framework for the integration of research and clinical care. But the digital element must be integrated with the human element. The routine and effective use of digital information should free up effort to fix the human components that are holding us back.
We’ve been trying to modernize clinical trial design for decades (factorial/sequential/adaptive designs for example). While some positive movement in the past month has been made, the research enterprise remains largely conservative when it comes to design modernization. How do we make more rapid progress?
#pctGR, #COVID19, @Collaboratory1, @Califf001